Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Archives of Clinical Psychiatry |
Texto Completo: | https://www.revistas.usp.br/acp/article/view/144875 |
Resumo: | Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations. |
id |
USP-5_c4663c9775aa489c1eef1025f237363d |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/144875 |
network_acronym_str |
USP-5 |
network_name_str |
Archives of Clinical Psychiatry |
repository_id_str |
|
spelling |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind studyNitric oxidesodium nitroprussideketamineschizophreniapsychosis Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations.Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria2017-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/acp/article/view/14487510.1590/0101-60830000000141Archives of Clinical Psychiatry; v. 44 n. 6 (2017); 149-153Archives of Clinical Psychiatry (São Paulo); Vol. 44 No. 6 (2017); 149-153Revista de Psiquiatria Clínica; Vol. 44 Núm. 6 (2017); 149-1531806-938X0101-6083reponame:Archives of Clinical Psychiatryinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/acp/article/view/144875/139102Copyright (c) 2018 Archives of Clinical Psychiatryinfo:eu-repo/semantics/openAccessRezende, Tatiana M. N.Maia-de-Oliveira, João PauloKandratavicius, LudmylaMachado-de-Sousa, João PauloAbrão, JoãoPrado, Daniel AlmeidaBressan, Rodrigo A.Lacerda, Acioly L. T.Zuardi, Antonio W.Baker, Glen B.Dursun, Serdar M.Hallak, Jaime E. C.2018-03-29T16:27:19Zoai:revistas.usp.br:article/144875Revistahttp://www.hcnet.usp.br/ipq/revista/index.htmlPUBhttps://old.scielo.br/oai/scielo-oai.php||archives@usp.br1806-938X0101-6083opendoar:2018-03-29T16:27:19Archives of Clinical Psychiatry - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study |
title |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study |
spellingShingle |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study Rezende, Tatiana M. N. Nitric oxide sodium nitroprusside ketamine schizophrenia psychosis |
title_short |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study |
title_full |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study |
title_fullStr |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study |
title_full_unstemmed |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study |
title_sort |
Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine – A translational double-blind study |
author |
Rezende, Tatiana M. N. |
author_facet |
Rezende, Tatiana M. N. Maia-de-Oliveira, João Paulo Kandratavicius, Ludmyla Machado-de-Sousa, João Paulo Abrão, João Prado, Daniel Almeida Bressan, Rodrigo A. Lacerda, Acioly L. T. Zuardi, Antonio W. Baker, Glen B. Dursun, Serdar M. Hallak, Jaime E. C. |
author_role |
author |
author2 |
Maia-de-Oliveira, João Paulo Kandratavicius, Ludmyla Machado-de-Sousa, João Paulo Abrão, João Prado, Daniel Almeida Bressan, Rodrigo A. Lacerda, Acioly L. T. Zuardi, Antonio W. Baker, Glen B. Dursun, Serdar M. Hallak, Jaime E. C. |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Rezende, Tatiana M. N. Maia-de-Oliveira, João Paulo Kandratavicius, Ludmyla Machado-de-Sousa, João Paulo Abrão, João Prado, Daniel Almeida Bressan, Rodrigo A. Lacerda, Acioly L. T. Zuardi, Antonio W. Baker, Glen B. Dursun, Serdar M. Hallak, Jaime E. C. |
dc.subject.por.fl_str_mv |
Nitric oxide sodium nitroprusside ketamine schizophrenia psychosis |
topic |
Nitric oxide sodium nitroprusside ketamine schizophrenia psychosis |
description |
Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/acp/article/view/144875 10.1590/0101-60830000000141 |
url |
https://www.revistas.usp.br/acp/article/view/144875 |
identifier_str_mv |
10.1590/0101-60830000000141 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/acp/article/view/144875/139102 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Archives of Clinical Psychiatry info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Archives of Clinical Psychiatry |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Medicina. Instituto de Psiquiatria |
dc.source.none.fl_str_mv |
Archives of Clinical Psychiatry; v. 44 n. 6 (2017); 149-153 Archives of Clinical Psychiatry (São Paulo); Vol. 44 No. 6 (2017); 149-153 Revista de Psiquiatria Clínica; Vol. 44 Núm. 6 (2017); 149-153 1806-938X 0101-6083 reponame:Archives of Clinical Psychiatry instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Archives of Clinical Psychiatry |
collection |
Archives of Clinical Psychiatry |
repository.name.fl_str_mv |
Archives of Clinical Psychiatry - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||archives@usp.br |
_version_ |
1824323913432170496 |